目前的药物治疗肺部类固醇症的最新技术
María Caridad Mata Salvador1, Joel Francesqui2, Jacobo Sellarés1
1Pulmonology Department, Hospital Clínic, WASOG Centre of Excellence, Respiratory Institute, Barcelona, Spain.
Expert opinion on pharmacotherapy
|July 8, 2024
概括
肺性类固醇症的治疗正在不断发展,除了皮质类固醇之外的新疗法. 免疫抑制剂,生物药物和抗纤维菌剂为耐火性或纤维菌性肺病提供了选择.
科学领域:
- 肺部医学 肺部医学
- 免疫学 免疫学 免疫学
- 药物治疗 药物治疗
背景情况:
- 沙丘病是一个复杂的慢性颗粒性疾病,主要影响肺部.
- 它的异质呈现和预后使治疗管理具有挑战性.
- 治疗的目的是防止器官损伤,缓解症状,提高生活质量.
研究的目的:
- 审查目前用于肺性沙丘病的药理疗法选择.
- 突出不断发展的治疗策略和新兴药物类别.
主要方法:
- 目前关于肺性沙丘症药物治疗的文献综述.
- 对治疗指南和临床试验数据的分析.
主要成果:
- 皮质类固醇仍然是第一线药物,但在长期或耐火病例中,免疫抑制剂是首选的.
- 生物药物代表了有前途的第三线疗法.
- 抗纤维素药物 (例如,宁泰达尼布) 和抗炎药物 (例如,efzofitimob) 分别显示出纤维素和炎症性肺病的潜力.
结论:
- 肺性沙尔科毒症的治疗正在使用新的治疗分子取得进展.
- 有限的数据和缺乏关于疾病监测的共识需要进一步的研究.
- 新兴疗法为管理这种具有挑战性的疾病提供了新的希望.
相关概念视频
COPD: Management Using Bronchodilators and Corticosteroids
194
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
194
Pulmonary Tuberculosis V
177
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Drug Therapy
41
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
41
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
234
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
234
Psychosis: Goals of Pharmacotherapy
119
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
119
Drugs Used in Lower Respiratory Disorders: Overview
397
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
397


